Guidance for industry [electronic resource] : animal models : essential elements to address efficacy under the animal rule
- Bib ID:
- 4597748
- Format:
- Book
- Online Access:
- http://purl.access.gpo.gov/GPO/LPS110484
Broken link? let us search Trove , the Wayback Machine , or Google for you.
- Description:
-
- Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) : Center for Biologics Evaluation and Research (CBER), [2009]
- 19 p. : digital, PDF file.
- Technical Details:
- Mode of access: Internet at the FDA Web site. Address as of 3/20/09: http://www.fda.gov/cder/guidance/8324dft.pdf ; current access is available via PURL.
- Notes:
-
- Title from PDF title page (viewed on Mar. 20, 2009).
- "Draft guidance."
- "January 2009."
- Subject:
- Other authors/contributors:
- Also Titled:
-
- Animal models
- Essential elements to address efficacy under the animal rule
- Govt. Doc. Number:
- HE 20.4802:AN 5
- Copyright:
-
In Copyright
You may copy under some circumstances, for example you may copy a portion for research or study. Order a copy through Copies Direct to the extent allowed under fair dealing. Contact us for further information about copying.
- Reason for copyright status:
- Until 2079 [Created/Published Date + 70 Years]
Copyright status was determined using the following information:
- Material type:
- Literary Dramatic Musical
- Published status:
- Published
- Publication date:
- 2009
Copyright status may not be correct if data in the record is incomplete or inaccurate. Other access conditions may also apply. For more information please see: Copyright in library collections.
Feedback
Similar items
- Animal models [electronic resource] : essential elements to address efficacy under the animal rule
- Guidance for industry [electronic resource] : source animal, product, preclinical, and clinical issues concerning the use of xenotransplantation products in humans
- Guidance for industry [electronic resource] : Q5A viral safety evaluation of biotechnology products derived from cell lines of human or animal origin
- Animal genetics
- Guidance for industry [electronic resource] : considerations for plasmid DNA vaccines for infectious disease indications